New pancreatic lipase inhibitor comprising indolyl oxoacetamide-quinazolinone analog for use in pharmaceutical composition for treating obesity
2023-08-16
专利权人BIRLA INST TECHNOLOGY & SCI PILANI (BIRL-Non-standard)
申请日期2023-08-16
专利号IN202311054774-A
成果简介NOVELTY - Pancreatic lipase inhibitor comprising indolyl oxoacetamide-quinazolinone analogs (I) and (II) are new. USE - Pancreatic lipase inhibitor comprising indolyl oxoacetamide-quinazolinone analog for use in pharmaceutical composition for treating obesity (all claimed). ADVANTAGE - None given. DETAILED DESCRIPTION - Pancreatic lipase inhibitor comprising indolyl oxoacetamide-quinazolinone analogs of formulae (I) and (II) are new. n=3; R1=H, 5-methoxy, 5-bromo, 6-bromo, 5-fluoro, 6-fluoro, or 7-benzyloxy; R2=methyl, ethyl, phenyl, benzyl, 4-chlorobenzyl, 4-fluorobenzyl, 4-bromobenzyl, 4-methylbenzyl, 4-cyanobenzyl, 3-methylbenzyl, benzyloxy; R3=H, 7-chloro-, 7-bromo-, or 6-iodo; and R1'=H, 2-methyl, 2-benzyl, 5-methoxy, 6-methoxy, 5-bromo, 6-bromo, 5-fluoro, 6-fluoro, 5-benzyloxy, 6-benzyloxy, or 7-benzyloxy. An INDEPENDENT CLAIM is included for a method for preparing (I) and (II).
IPC 分类号A61K-031/365 ; A61K-031/405 ; A61P-003/04 ; C07D-239/91
国家印度
专业领域医药卫生
语种英语
成果类型专利
文献类型科技成果
条目标识符http://119.78.100.226:8889/handle/3KE4DYBR/20801
专题中国科学院新疆生态与地理研究所
作者单位
BIRLA INST TECHNOLOGY & SCI PILANI (BIRL-Non-standard)
推荐引用方式
GB/T 7714
ASHOKRAO J U,ARIJIT N,AUTI P S,et al. New pancreatic lipase inhibitor comprising indolyl oxoacetamide-quinazolinone analog for use in pharmaceutical composition for treating obesity. IN202311054774-A[P]. 2023.
条目包含的文件
条目无相关文件。
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。